Issue 17 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

22

No.

17

April 26, 1996Apr 26, 1996

Free

DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

Centers May Become More specialized, Klausner Tells AACI

NIH, NCI Being Discussions With HCFA On Reimbursement

Recent Issues

Volume 51 | Issue 13 - April 04, 2025

Volume 51 | Issue 12 - March 28, 2025

Volume 51 | Issue 11 - March 21, 2025

Volume 51 | Issue 10 - March 14, 2025

Volume 51 | Issue 09 - March 07, 2025

Volume 51 | Issue 08 - February 28, 2025